Artificial intelligence (AI) and predictive radiomics models that will be a boon to…
It’s a scene that some cancer patients dream about: celebrating the end of a course of…
Nanobiotix has announced its global development strategy for 2020 and beyond, following…
Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad…
Accuray Incorporated has announced that data from a prospective study shows that at five…
Numerous studies have shown that monitoring physical activity promotes better health –…
Proton therapy leads to significantly lower risk of side effects severe enough to lead to…
Ductal carcinoma in-situ (DCIS) accounts for one-fifth of breast cancer cases in the United…
Nanabiotix, a clinical-stage nanomedicine company pioneering new approaches to the treatment…
CAPTION: Timothy Whelan is a professor of oncology at McMaster University and a radiation…
